SCHEMBL7904443

SCHEMBL7904443

CC(C)=CCN1C(C)c2cc(Cl)cc(N)c2NC[C@@H]1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7904440 1.00
SCHEMBL7904422 0.83 PRCP (0.36)
SCHEMBL7904425 0.83 PRCP (0.36)
SCHEMBL7902288 0.83 PRCP (0.36)
SCHEMBL7903496 0.78 SIGMAR1 (0.32)
SCHEMBL8844986 0.66 SIGMAR1 (0.33)
SCHEMBL7902097 0.63 SIGMAR1 (0.34)
SCHEMBL7908084 0.61 HRH4 (0.35)
SCHEMBL7903491 0.58 SIGMAR1 (0.32)
SCHEMBL9387637 0.57 HTR1A (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6201119-B1 2,3,4,5-TETRAHYDRO-1H-1,4-BENZODIAZEPIN-9-AMINE COMPOUNDS USEFUL AS INTERMEDIATES TO ANTIVIRALS JANSSEN PHARMACEUTICA N.V. (BE) 2001-03-13 US disclosed
US-5371079-A Administering to inhibit replication of HIV-1 in human cells JANSSEN PHARMACEUTICA N.V. (BE) 1994-12-06 US disclosed
US-5270464-A Anti-HIV-1 tetrahydroimidazo[1,4]benzodiazepin-2-(thi) ones JANSSEN PHARMACEUTICA N.V. (BE) 1993-12-14 US disclosed